1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Sarcoma, Kaposi in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balestrieri, C; Boccellino, M; Calderaro, V; Camussi, G; Ferro, L; Giovane, A; Quagliuolo, L | 1 |
| Balestrieri, C; Balestrieri, ML; Felice, F; Montoro, P; Oleszek, W; Piacente, S; Pizza, C; Visciano, V | 1 |
| Aglietta, M; Arese, M; Barra, L; Benelli, R; Bussolino, F; Ghigo, D; Montrucchio, G; Primo, L; Rola-Pleszczynski, MR; Sanavio, F | 1 |
| Brandstetter, H; Bussolino, F; Matteucci, C; Peri, G; Sciacca, FL; Sironi, M; Sozzani, S; Stürzl, M; Zhou, D; Zietz, C | 1 |
| Albini, A; Biancone, L; Boccellino, M; Bussolati, B; Camussi, G; Cantaluppi, V; Conaldi, PG; Del Sorbo, L; Toniolo, A | 1 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Sarcoma, Kaposi
| Article | Year |
|---|---|
Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility.
Topics: alpha Catenin; Antigens, CD; beta Catenin; Cadherins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cytoskeletal Proteins; Humans; Phosphorylation; Platelet Activating Factor; Sarcoma, Kaposi; Tissue Distribution; Trans-Activators; Ubiquitin | 2005 |
Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis.
Topics: Antineoplastic Agents; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Bark; Plant Extracts; Platelet Activating Factor; Resveratrol; Sarcoma, Kaposi; Spiro Compounds; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Yucca | 2006 |
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
Topics: Aged; Animals; Azepines; Base Sequence; Cell Line; Chemotaxis; Choriocarcinoma; Collagen; Culture Media, Conditioned; Cytokines; Dogs; Drug Combinations; Endothelium, Vascular; Female; Growth Substances; Humans; Interleukin-1; Laminin; Lymphoma, Large B-Cell, Diffuse; Macrophages; Male; Mice; Mice, Inbred DBA; Molecular Sequence Data; Neoplasm Proteins; Neovascularization, Pathologic; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteoglycans; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sarcoma, Kaposi; Skin Neoplasms; Thrombin; Triazoles; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins; Uterine Neoplasms | 1995 |
Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells.
Topics: Base Sequence; Blotting, Northern; Cell Adhesion Molecules; Chemotactic Factors; Flow Cytometry; Humans; In Situ Hybridization; Molecular Sequence Data; Platelet Activating Factor; Polymerase Chain Reaction; Sarcoma, Kaposi; Tumor Cells, Cultured | 1994 |
Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
Topics: Azepines; Cell Movement; Diterpenes; Dose-Response Relationship, Drug; Fibrinolytic Agents; Gene Products, tat; Ginkgolides; HIV-1; Humans; Lactones; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sarcoma, Kaposi; tat Gene Products, Human Immunodeficiency Virus; Triazoles; Tumor Cells, Cultured | 1999 |